Joel Greenblatt’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
Other funds holding ABCL
BBA
Joel Greenblatt's ABCL Position: Q3 2026 in Review
Joel Greenblatt opened a new position in AbCellera Biologics (ABCL) in Q3 2026: 17,318 shares worth $253K. The stake represents ﹤0.01% of the portfolio and ranks #1745 among its holdings. This is a return to the name: Joel Greenblatt previously reported a position in ABCL as recently as Q2 2023.
Joel Greenblatt first reported a position in ABCL in Q2 2021 and has held it in 8 quarters since. The position peaked at $1.46M in Q3 2021. 164 funds tracked by Wall St. Rank hold ABCL as of Q3 2026.
- Joel Greenblatt held 17,318 shares of AbCellera Biologics worth $253K as of Q3 2026.
- AbCellera Biologics was a new Joel Greenblatt position in Q3 2026.
- AbCellera Biologics made up ﹤0.01% of Joel Greenblatt's portfolio in Q3 2026, its #1745 holding.
- Joel Greenblatt first reported a position in AbCellera Biologics in Q2 2021 and has held it in 8 quarters since.
- Joel Greenblatt's AbCellera Biologics position peaked at $1.46M in Q3 2021.
- 164 funds tracked by Wall St. Rank held AbCellera Biologics as of Q3 2026.
Based on Gotham Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.